Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

Patient-reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Ohanian M, Shah ND, Shelburne SA, Futreal A, Kontoyiannis DP, Heijnen CJ.

Oncotarget. 2018 Jul 27;9(58):31244-31252. doi: 10.18632/oncotarget.25787. eCollection 2018 Jul 27.

2.

Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia.

Folan SA, Marx KR, Tverdek FP, Raad I, Mulanovich VE, Tarrand JJ, Shelburne SA, Aitken SL.

Open Forum Infect Dis. 2018 Jul 13;5(7):ofy167. doi: 10.1093/ofid/ofy167. eCollection 2018 Jul.

3.

Capsule-Negative emm Types Are an Increasing Cause of Pediatric Group A Streptococcal Infections at a Large Pediatric Hospital in Texas.

Flores AR, Chase McNeil J, Shah B, Van Beneden C, Shelburne SA 3rd.

J Pediatric Infect Dis Soc. 2018 Aug 1. doi: 10.1093/jpids/piy053. [Epub ahead of print]

PMID:
30085121
4.

In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer.

Rolston KVI, Reitzel R, Vargas-Cruz N, Shelburne SA, Raad II, Prince RA.

Diagn Microbiol Infect Dis. 2018 Aug;91(4):351-353. doi: 10.1016/j.diagmicrobio.2018.03.009. Epub 2018 Mar 16.

PMID:
29661529
5.

Association of daptomycin dosing regimen and mortality in patients with VRE bacteraemia: a review.

Foolad F, Taylor BD, Shelburne SA, Arias CA, Aitken SL.

J Antimicrob Chemother. 2018 Sep 1;73(9):2277-2283. doi: 10.1093/jac/dky072.

PMID:
29547977
6.

Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.

Li X, Arias CA, Aitken SL, Galloway Peña J, Panesso D, Chang M, Diaz L, Rios R, Numan Y, Ghaoui S, DebRoy S, Bhatti MM, Simmons DE, Raad I, Hachem R, Folan SA, Sahasarabhojane P, Kalia A, Shelburne SA.

Clin Infect Dis. 2018 Jul 18;67(3):398-406. doi: 10.1093/cid/ciy089.

PMID:
29546356
7.

Associations of inflammation with symptom burden in patients with acute myeloid leukemia.

Lacourt TE, Kavelaars A, Galloway-Peña JR, Sahasrabhojane PV, Shah ND, Futreal A, Kontoyiannis DP, Shelburne SA, Heijnen CJ.

Psychoneuroendocrinology. 2018 Mar;89:203-208. doi: 10.1016/j.psyneuen.2018.01.018.

PMID:
29414033
8.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Szczepaniak Sloane R, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Marcelo Riquelme Sanchez E, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA.

Science. 2018 Jan 5;359(6371):97-103. doi: 10.1126/science.aan4236. Epub 2017 Nov 2.

9.

Impact of the Microbiota on Bacterial Infections during Cancer Treatment.

Galloway-Peña J, Brumlow C, Shelburne S.

Trends Microbiol. 2017 Dec;25(12):992-1004. doi: 10.1016/j.tim.2017.06.006. Epub 2017 Jul 17. Review.

PMID:
28728967
10.

Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.

Reyes-Gibby CC, Melkonian SC, Wang J, Yu RK, Shelburne SA, Lu C, Gunn GB, Chambers MS, Hanna EY, Yeung SJ, Shete S.

PLoS One. 2017 Jul 5;12(7):e0180396. doi: 10.1371/journal.pone.0180396. eCollection 2017. Review.

11.

Whole-Genome Sequencing Accurately Identifies Resistance to Extended-Spectrum β-Lactams for Major Gram-Negative Bacterial Pathogens.

Shelburne SA, Kim J, Munita JM, Sahasrabhojane P, Shields RK, Press EG, Li X, Arias CA, Cantarel B, Jiang Y, Kim MS, Aitken SL, Greenberg DE.

Clin Infect Dis. 2017 Sep 1;65(5):738-745. doi: 10.1093/cid/cix417.

12.

Cluster of Fatal Group A Streptococcal emm87 Infections in a Single Family: Molecular Basis for Invasion and Transmission.

Flores AR, Luna RA, Runge JK, Shelburne SA 3rd, Baker CJ.

J Infect Dis. 2017 Jun 1;215(11):1648-1652. doi: 10.1093/infdis/jix177.

PMID:
28383686
13.

Erratum to: An integrative Bayesian Dirichlet-multinomial regression model for the analysis of taxonomic abundances in microbiome data.

Wadsworth WD, Argiento R, Guindani M, Galloway-Pena J, Shelburne SA, Vannucci M.

BMC Bioinformatics. 2017 Mar 23;18(1):185. doi: 10.1186/s12859-017-1606-z. No abstract available.

14.

Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa.

Munita JM, Aitken SL, Miller WR, Perez F, Rosa R, Shimose LA, Lichtenberger PN, Abbo LM, Jain R, Nigo M, Wanger A, Araos R, Tran TT, Adachi J, Rakita R, Shelburne S, Bonomo RA, Arias CA.

Clin Infect Dis. 2017 Jul 1;65(1):158-161. doi: 10.1093/cid/cix014.

15.

Can Consideration of the Microbiome Improve Antimicrobial Utilization and Treatment Outcomes in the Oncology Patient?

Galloway-Peña JR, Jenq RR, Shelburne SA.

Clin Cancer Res. 2017 Jul 1;23(13):3263-3268. doi: 10.1158/1078-0432.CCR-16-3173. Epub 2017 Mar 15. Review.

16.

Use of a Phosphorylation Site Mutant To Identify Distinct Modes of Gene Repression by the Control of Virulence Regulator (CovR) in Streptococcus pyogenes.

Horstmann N, Sahasrabhojane P, Yao H, Su X, Shelburne SA.

J Bacteriol. 2017 Aug 22;199(18). pii: e00835-16. doi: 10.1128/JB.00835-16. Print 2017 Sep 15.

17.

In vitro activity of ceftaroline and comparator agents against Gram-positive and Gram-negative clinical isolates from cancer patients.

Rolston KVI, Jamal MA, Nesher L, Shelburne SA, Raad I, Prince RA.

Int J Antimicrob Agents. 2017 Apr;49(4):416-421. doi: 10.1016/j.ijantimicag.2016.12.016. Epub 2017 Feb 28.

PMID:
28257904
18.

Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Wadsworth WD, Fellman BM, Ajami NJ, Shpall EJ, Daver N, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Genome Med. 2017 Feb 28;9(1):21. doi: 10.1186/s13073-017-0409-1.

19.

The Growing Threat of Antimicrobial Resistance.

Munita JM, Shelburne S, Greenberg DE, Arias CA.

Tex Med. 2017 Feb 1;113(2):48-52.

PMID:
28207079
20.

Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans Causing a Human Bloodstream Infection.

Bhatti MD, Kalia A, Sahasrabhojane P, Kim J, Greenberg DE, Shelburne SA.

Front Microbiol. 2017 Jan 24;8:62. doi: 10.3389/fmicb.2017.00062. eCollection 2017.

21.

Daptomycin non-susceptible Enterococcus faecium in leukemia patients: Role of prior daptomycin exposure.

DiPippo AJ, Tverdek FP, Tarrand JJ, Munita JM, Tran TT, Arias CA, Shelburne SA, Aitken SL.

J Infect. 2017 Mar;74(3):243-247. doi: 10.1016/j.jinf.2016.11.004. Epub 2016 Nov 11.

22.

A Multi-Serotype Approach Clarifies the Catabolite Control Protein A Regulon in the Major Human Pathogen Group A Streptococcus.

DebRoy S, Saldaña M, Travisany D, Montano A, Galloway-Peña J, Horstmann N, Yao H, González M, Maass A, Latorre M, Shelburne SA.

Sci Rep. 2016 Sep 1;6:32442. doi: 10.1038/srep32442.

23.

Successful Treatment of Bloodstream Infection Due to Metallo-β-Lactamase-Producing Stenotrophomonas maltophilia in a Renal Transplant Patient.

Mojica MF, Ouellette CP, Leber A, Becknell MB, Ardura MI, Perez F, Shimamura M, Bonomo RA, Aitken SL, Shelburne SA.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5130-4. doi: 10.1128/AAC.00264-16. Print 2016 Sep.

24.

High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream Infections at a Major Cancer Center.

Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KVI, Jones RN, Castanheira M, Chemaly RF.

Clin Infect Dis. 2016 Oct 1;63(7):954-958. doi: 10.1093/cid/ciw398. Epub 2016 Jun 16.

PMID:
27313265
25.

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.

Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA.

Cancer. 2016 Jul 15;122(14):2186-96. doi: 10.1002/cncr.30039. Epub 2016 May 3.

26.

Intergenic Variable-Number Tandem-Repeat Polymorphism Upstream of rocA Alters Toxin Production and Enhances Virulence in Streptococcus pyogenes.

Zhu L, Olsen RJ, Horstmann N, Shelburne SA, Fan J, Hu Y, Musser JM.

Infect Immun. 2016 Jun 23;84(7):2086-2093. doi: 10.1128/IAI.00258-16. Print 2016 Jul.

27.

Complete Genome Sequence of Streptococcus mitis Strain SVGS_061 Isolated from a Neutropenic Patient with Viridans Group Streptococcal Shock Syndrome.

Petrosyan V, Holder M, Ajami NJ, Petrosino JF, Sahasrabhojane P, Thompson EJ, Kalia A, Shelburne SA.

Genome Announc. 2016 Apr 7;4(2). pii: e00259-16. doi: 10.1128/genomeA.00259-16.

28.

Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA.

Clin Infect Dis. 2016 Jun 15;62(12):1514-1520. doi: 10.1093/cid/ciw173. Epub 2016 Apr 3.

29.

Application of Whole-Genome Sequencing to an Unusual Outbreak of Invasive Group A Streptococcal Disease.

Galloway-Peña J, Clement ME, Sharma Kuinkel BK, Ruffin F, Flores AR, Levinson H, Shelburne SA, Moore Z, Fowler VG Jr.

Open Forum Infect Dis. 2016 Feb 19;3(1):ofw042. doi: 10.1093/ofid/ofw042. eCollection 2016 Jan.

30.

In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.

Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA.

J Antibiot (Tokyo). 2016 May;69(5):381-7. doi: 10.1038/ja.2015.120. Epub 2015 Dec 2.

PMID:
26626876
31.

Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.

Shelburne SA, Ajami NJ, Chibucos MC, Beird HC, Tarrand J, Galloway-Peña J, Albert N, Chemaly RF, Ghantoji SS, Marsh L, Pemmaraju N, Andreeff M, Shpall EJ, Wargo JA, Rezvani K, Alousi A, Bruno VM, Futreal PA, Petrosino JF, Kontoyiannis DP.

PLoS One. 2015 Nov 10;10(11):e0139851. doi: 10.1371/journal.pone.0139851. eCollection 2015.

32.

Regulatory rewiring confers serotype-specific hyper-virulence in the human pathogen group A Streptococcus.

Miller EW, Danger JL, Ramalinga AB, Horstmann N, Shelburne SA, Sumby P.

Mol Microbiol. 2015 Oct;98(3):473-89. doi: 10.1111/mmi.13136. Epub 2015 Aug 14.

33.

Emergence of Serotype IV Group B Streptococcus Adult Invasive Disease in Manitoba and Saskatchewan, Canada, Is Driven by Clonal Sequence Type 459 Strains.

Teatero S, Athey TB, Van Caeseele P, Horsman G, Alexander DC, Melano RG, Li A, Flores AR, Shelburne SA 3rd, McGeer A, Demczuk W, Martin I, Fittipaldi N.

J Clin Microbiol. 2015 Sep;53(9):2919-26. doi: 10.1128/JCM.01128-15. Epub 2015 Jul 1.

34.

Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes.

Flores AR, Galloway-Peña J, Sahasrabhojane P, Saldaña M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, Margarit Y Ros I, Rosini R, Grandi G, Horstmann N, Teatero S, McGeer A, Fittipaldi N, Rappuoli R, Baker CJ, Shelburne SA.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):6431-6. doi: 10.1073/pnas.1504725112. Epub 2015 May 4.

35.

Characterization of the effect of the histidine kinase CovS on response regulator phosphorylation in group A Streptococcus.

Horstmann N, Sahasrabhojane P, Saldaña M, Ajami NJ, Flores AR, Sumby P, Liu CG, Yao H, Su X, Thompson E, Shelburne SA.

Infect Immun. 2015 Mar;83(3):1068-77. doi: 10.1128/IAI.02659-14. Epub 2015 Jan 5.

36.

The identification and functional characterization of WxL proteins from Enterococcus faecium reveal surface proteins involved in extracellular matrix interactions.

Galloway-Peña JR, Liang X, Singh KV, Yadav P, Chang C, La Rosa SL, Shelburne S, Ton-That H, Höök M, Murray BE.

J Bacteriol. 2015 Mar;197(5):882-92. doi: 10.1128/JB.02288-14. Epub 2014 Dec 15.

37.

Invasive gram-positive bacterial infection in cancer patients.

Holland T, Fowler VG Jr, Shelburne SA 3rd.

Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S331-4. doi: 10.1093/cid/ciu598. Review.

38.

Identification and characterization of catheter-related bloodstream infections due to viridans group streptococci in patients with cancer.

Shelburne SA 3rd, Chaftari AM, Jamal M, Al Wohoush I, Jiang Y, Abughazaleh S, Cairo J, Raad S, Debiane L, Raad I.

Am J Infect Control. 2014 Oct;42(10):1127-9. doi: 10.1016/j.ajic.2014.06.012.

PMID:
25278410
39.

Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.

Flores AR, Jewell BE, Olsen RJ, Shelburne SA 3rd, Fittipaldi N, Beres SB, Musser JM.

Infect Immun. 2014 Sep;82(9):3958-67. doi: 10.1128/IAI.01788-14. Epub 2014 Jul 14.

40.

GyrB polymorphisms accurately assign invasive viridans group streptococcal species.

Galloway-Peña J, Sahasrabhojane P, Tarrand J, Han XY, Shelburne SA.

J Clin Microbiol. 2014 Aug;52(8):2905-12. doi: 10.1128/JCM.01068-14. Epub 2014 Jun 4.

41.

In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.

Rolston K 6th, Wang W, Nesher L, Coyle E, Shelburne S, Prince RA.

J Antibiot (Tokyo). 2014 Jul;67(7):505-9. doi: 10.1038/ja.2014.30. Epub 2014 May 14.

PMID:
24824818
42.

Dual-site phosphorylation of the control of virulence regulator impacts group a streptococcal global gene expression and pathogenesis.

Horstmann N, Saldaña M, Sahasrabhojane P, Yao H, Su X, Thompson E, Koller A, Shelburne SA 3rd.

PLoS Pathog. 2014 May 1;10(5):e1004088. doi: 10.1371/journal.ppat.1004088. eCollection 2014 May.

43.

Development and validation of a clinical model to predict the presence of β-lactam resistance in viridans group streptococci causing bacteremia in neutropenic cancer patients.

Shelburne SA 3rd, Lasky RE, Sahasrabhojane P, Tarrand JT, Rolston KV.

Clin Infect Dis. 2014 Jul 15;59(2):223-30. doi: 10.1093/cid/ciu260. Epub 2014 Apr 21.

PMID:
24755857
44.

Streptococcus mitis strains causing severe clinical disease in cancer patients.

Shelburne SA, Sahasrabhojane P, Saldana M, Yao H, Su X, Horstmann N, Thompson E, Flores AR.

Emerg Infect Dis. 2014 May;20(5):762-71. doi: 10.3201/eid2005.130953.

45.

Species-level assessment of the molecular basis of fluoroquinolone resistance among viridans group streptococci causing bacteraemia in cancer patients.

Sahasrabhojane P, Galloway-Peña J, Velazquez L, Saldaña M, Horstmann N, Tarrand J, Shelburne SA.

Int J Antimicrob Agents. 2014 Jun;43(6):558-62. doi: 10.1016/j.ijantimicag.2014.01.031. Epub 2014 Mar 27.

PMID:
24721231
46.

Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management.

El Zakhem A, Chaftari AM, Bahu R, El Helou G, Shelburne S, Jiang Y, Hachem R, Raad I.

Ann Med. 2014 May;46(3):163-8. doi: 10.3109/07853890.2013.878513. Epub 2014 Feb 4.

PMID:
24491173
47.

Molecular characterization of an invasive phenotype of group A Streptococcus arising during human infection using whole genome sequencing of multiple isolates from the same patient.

Flores AR, Sahasrabhojane P, Saldaña M, Galloway-Peña J, Olsen RJ, Musser JM, Shelburne SA.

J Infect Dis. 2014 May 15;209(10):1520-3. doi: 10.1093/infdis/jit674. Epub 2013 Dec 4.

48.

Natural variation in the promoter of the gene encoding the Mga regulator alters host-pathogen interactions in group a Streptococcus carrier strains.

Flores AR, Olsen RJ, Wunsche A, Kumaraswami M, Shelburne SA 3rd, Carroll RK, Musser JM.

Infect Immun. 2013 Nov;81(11):4128-38. doi: 10.1128/IAI.00405-13. Epub 2013 Aug 26.

49.

Streptococcal infections: understanding the various species and strains.

White CN, Shelburne S.

JAAPA. 2012 Nov;25(11):23-4. No abstract available.

PMID:
23620919
50.

Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000-2011.

Shelburne SA 3rd, Tarrand J, Rolston KV.

J Infect. 2013 Feb;66(2):136-46. doi: 10.1016/j.jinf.2012.11.007. Epub 2012 Nov 23.

PMID:
23182968

Supplemental Content

Loading ...
Support Center